Abstract

Introduction: Desmoid tumors, also known as aggressive fibromatosis, grow slowly but are locally aggressive. The therapy strategy consists of surgery, and radiation. Systemic therapy with non-steroidal anti-inflammatory drugs, antiestrogen compounds, cytotoxic chemotherapy and protein kinase inhibitors are recommended for recurrence, unresectable, advanced disease and failure to response to primary treatment. Case Presentation: We report on a 35-year-old female patient with advanced fibromatosis of the soft tissue of neck who has been treated with triple therapy including 8 cycles of Doxorubicin, Tamoxifen daily, and Imatinib daily. Tumor response was evaluated clinically and by enhanced CT SCAN imaging. Conclusions: 90% reduction in tumor size occurred after 6 months of treatment. The response continued and after 8 courses of doxorobicine treatment switched to triple therapy with imatinib , tamoifen and celexocib

Authors and Affiliations